Barna Nicole 4
4 · Codiak BioSciences, Inc. · Filed Jan 23, 2023
Insider Transaction Report
Form 4
Barna Nicole
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-01-19−2,167→ 4,333 total→ Common Stock (2,167 underlying) - Exercise/Conversion
Common Stock
2023-01-19+2,167→ 8,948.257 total - Sale
Common Stock
2023-01-20$0.57/sh−836$481→ 8,112.257 total
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On January 19, 2022, the reporting person was granted 6,500 RSUs, vesting in three equal annual installments beginning on the first anniversary of the grant date.